MYLUNG Consortium Part 3: Observational Study
Recruiting · NCT05885698 · Observational (researchers observe without assigning treatment) · Lead sponsor: US Oncology Research
View the official record on ClinicalTrials.gov →What this trial is about
This longitudinal study looks to quantify the testing timeline, operational barriers, and outcomes of biomarker-guided therapy in a large, community-based, and largely unselected patient population with early stage and advanced stage, treatment-naive non-small cell lung cancer, whether squamous or non-squamous.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Adult subjects (18 years and older) with newly diagnosed early stage, locally advanced or metastatic non-small cell lung cancer
- Must be eligible for systemic therapy based on the treating provider's assessment. If systemic therapy was recommended and documented by the treating provider but the patient declined, they can still be eligible for the study. Patients can be enrolled prior to start of treatment.
- Subjects who developed locally advanced or metastatic disease after receiving adjuvant or neoadjuvant therapy are eligible if the adjuvant/neoadjuvant therapy was completed at least 12 months prior to the development of locally advanced or metastatic disease
- Subjects must be enrolled within 30 days of initiation of systemic therapy
- Signed informed consent
Exclusion criteria
- Stage IA at the time of enrollment
- Subjects with small cell lung cancer
- Subjects with Unknown primary tumor origin
Where it is running
17 locations listed across 12 US states.
- Southern Cancer Center, PC - Daphne, Alabama, United States
- Arizona Oncology Associates, PC - NAHOA - Prescott Valley, Arizona, United States
- Rocky Mountain Cancer Center - Denver, Colorado, United States
- Cancer Care Centers of Brevard, Inc. - Palm Bay, Florida, United States
- Woodlands Medical Specialists, PA - Pensacola, Florida, United States
- Affiliated Oncologists, LLC - Chicago Ridge, Illinois, United States
- Illinois Cancer Specialists - Niles, Illinois, United States
- Maryland Oncology Hematology, P.A. - Silver Spring, Maryland, United States
- Minnesota Oncology Hematology, P.A. - Minneapolis, Minnesota, United States
- New York Oncology Hematology, P.C. - Albany, New York, United States
- Oncology Hematology Care Clinical Trials, LLC - Cincinnati, Ohio, United States
- Willamette Valley Cancer Institute and Research Center - Eugene, Oregon, United States
- Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care - Blacksburg, Virginia, United States
- Virginia Cancer Specialists, PC - Fairfax, Virginia, United States
- Virginia Oncology Associates - Newport News, Virginia, United States
- Shenandoah Oncology, P.C. - Winchester, Virginia, United States
- Northwest Cancer Specialists, P.C. - Vancouver, Washington, United States